These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9626990)

  • 1. Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration.
    Lanir N; Zilberman M; Yron I; Tennenbaum G; Shechter Y; Brenner B
    J Lab Clin Med; 1998 Jun; 131(6):548-56. PubMed ID: 9626990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome.
    Mason AN; Harmer IJ; Mageed RA; Mackworth-Young CG
    Lupus; 1999; 8(3):234-9. PubMed ID: 10342717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes.
    Hill MB; Phipps JL; Hughes P; Greaves M
    Br J Haematol; 1998 Nov; 103(2):416-21. PubMed ID: 9827913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
    Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
    J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
    Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
    Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ; von Landenberg C; Barlage S; Schmitz G
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1990 Apr; 63(2):169-73. PubMed ID: 2114042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
    Barbati C; Stefanini L; Colasanti T; Cipriano E; Celia A; Gabriele G; Vomero M; Ceccarelli F; Spinelli FR; Finucci A; Speziali M; Orso G; Margiotta DPE; Conti F; Violi F; Afeltra A; Valesini G; Alessandri C
    Arthritis Res Ther; 2019 Jul; 21(1):161. PubMed ID: 31262358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
    Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
    Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
    Alessandri C; Sorice M; Bombardieri M; Conigliaro P; Longo A; Garofalo T; Manganelli V; Conti F; Esposti MD; Valesini G
    Arthritis Res Ther; 2006; 8(6):R180. PubMed ID: 17150088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the pathogenetic role of antiphospholipid antibodies?
    Meroni PL; Tincani A; Barcellini W; Del Papa N; Gambini D; Piona A; La Rosa L; Balestrieri G
    Clin Exp Rheumatol; 1994; 12 Suppl 10():S43-7. PubMed ID: 7955626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options.
    Feldmann E; Levine SR
    Ann Neurol; 1995 May; 37 Suppl 1():S114-30. PubMed ID: 8968222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction].
    Forastiero RR; Martinuzzo ME; Carreras LO
    Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.